top of page
Companies in the News
GlaxoSmithKline doubles down on Vir pact, throwing in $345M upfront to go beyond COVID-19
Last year, Big Pharma GlaxoSmithKline and George Scangos’ biotech Vir joined forces against COVID-19. Now, the pair is turning its...
Feb 17, 2021
Nuvation Bio Closes Transaction with Panacea, Debuts as Publicly Traded Oncology Company
Combined company renamed Nuvation Bio Inc., will be listed on the New York Stock Exchange under ticker symbol "NUVB" Strong cash position...
Feb 11, 2021
Sana snags $587.5M IPO to catapult cell therapies into the clinic
Massive private raise? Check. Preclinical pipeline? Check. Now, Sana Biotechnology is raising $587.5 million in a mammoth IPO that will...
Feb 4, 2021
Gilead Sciences and Gritstone Announce Collaboration For HIV Cure
FOSTER CITY, Calif. and EMERYVILLE, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Gilead Sciences, Inc. (Nasdaq: GILD) and Gritstone...
Feb 1, 2021
Gritstone Advances Second Generation COVID-19 Vaccine “CORAL” Program with Support from NIAID
EMERYVILLE, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company...
Jan 20, 2021
Tessera Therapeutics Attracts Over $230M in Series B Financing to Advance ‘Gene Writing’
SoftBank Vision Fund 2, Alaska Permanent Fund Corporation, Altitude Life Science Ventures, Qatar Investment Authority, and Other New...
Jan 12, 2021


Top Life Sciences Startups to Watch in 2021
BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life sciences companies in North America that...
Jan 7, 2021
Beam Therapeutics Presents Updated Data from Novel Base Editing Programs for Sickle Cell Disease
BEAM-101 Data Highlight Precision of Base Editor with No Off-Target Editing Observed; Will Support Planned IND Submission in the Second...
Dec 7, 2020
Gritstone Oncology Advances into Phase 2 Expansion Cohorts for its Personalized Neoantigen Therapy
EMERYVILLE, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Gritstone Oncology Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company...
Nov 2, 2020
bottom of page